Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for treatment and prophylaxis of COVID-19
PACTR202102535686338Phase 3Not yet recruiting
- Sponsor
- Lagos State Ministry of Health
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ivermectin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Lagos State Ministry of Health. Primary endpoints: Mortality by day 7, Resolution of symptoms and 1 more. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202102535686338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102535686338.